Ποια είναι η τιμή για Apollo Endosurgery, Inc. (APEN)

Η τιμή για Apollo Endosurgery, Inc. (APEN) είναι $10.00

Ποια είναι η κεφαλαιοποίηση αγοράς για Apollo Endosurgery, Inc. (APEN)

Η κεφαλαιοποίηση αγοράς για Apollo Endosurgery, Inc. (APEN) είναι $214.01M

Apollo Endosurgery, Inc. (APEN) Τιμή και Κεφαλαιοποίηση Αγοράς

Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System. This system aids in weight management by decreasing stomach capacity and slowing gastric emptying, thereby encouraging reduced food intake. Additionally, it provides the X-Tack Endoscopic HeliX Tacking System, a suture-based device designed for repairing defects in both the upper and lower gastrointestinal tract. Its medical solutions are distributed to various healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, across the United States, Australia, Costa Rica, and several European nations. Founded in 2005, Apollo Endosurgery, Inc. maintains its headquarters in Austin, Texas.

Η τιμή για APEN	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$253,459 $214.01M	NVDA	$5.424T	+2,534,492.68%
$223,161 $214.01M	AAPL	$4.776T	+2,231,514.29%
$189,328 $214.01M	GOOG	$4.052T	+1,893,178.55%
$172,470 $214.01M	MSFT	$3.691T	+1,724,600.41%
$128,229 $214.01M	AMZN	$2.744T	+1,282,194.35%

Η τιμή για APEN

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$253,459 $214.01M